Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Feb 19 2026

Full Issue

Viewpoints: ICE Is Causing A Health Crisis; FDA’s Reversal On Moderna Vaccine Can't Undo The Damage

Editorial writers examine these public health issues.

The New York Times: 'Our Patients Are More Frightened And Sicker Than Ever'

Our patients face a cruel calculus: seek essential medical care and risk detention, or stay home and risk their lives. (Elizabeth Whidden, Robin Canada and D. Daphne Owen, 2/19)

The Washington Post: FDA’s Reversal On Moderna’s Flu Vaccine Won’t Repair All The Damage 

Moderna is breathing a sigh of relief now that the Food and Drug Administration said on Wednesday that it will review the company’s application for a new flu vaccine — a dramatic reversal from the agency’s refusal to do so just a week ago. (2/18)

The New York Times: The MAHA Coalition Is Falling Apart

It’s been a bumpy year for public health. Even so, last week’s precedent-breaking news that the F.D.A. wouldn’t even bother to consider Moderna’s new mRNA flu vaccine for approval felt like a dark revelation. (David Wallace-Wells, 2/18)

Stat: How GLP-1 Use And Eating Disorders Intersect 

It makes my head spin to think about how much GLP-1s have changed the medical weight management landscape in such a short time. We’ve gone from weight loss drug shortages to a problem of excess — and eating disorders. (Jody Dushay, 2/19)

Stat: What I Learned From Psychedelics: The Guides, Not The Drug, Are Key 

During my first psychedelic session, a violin flourish turned the sky yellow. A comet’s tail of severed body parts flew past and receded behind me. Speaking with the guides and study staff in the hours and days that followed, I came to understand the humor: Breast cancer was not who I was. The imagery provided a metaphorical lens through which I could view my illness. (Erica Rex, 2/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF